133 results
Page 3 of 7
DEFA14A
srak2utnzyto9
28 Apr 22
Additional proxy soliciting materials
4:58pm
8-K
EX-1.1
oe9 ql0ld3
13 Apr 22
Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
4:26pm
424B5
hel91 fgxux0ye
13 Apr 22
Prospectus supplement for primary offering
4:22pm
S-8
r1jnh 5df2
30 Mar 22
Registration of securities for employees
7:07pm
S-8
EX-23.2
5uvyg6b
30 Mar 22
Registration of securities for employees
7:07pm
8-K
EX-99.2
hh1 cwa68egwwuo
30 Mar 22
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results
4:05pm
8-K
jrva59 qgaqt9pi
14 Mar 22
Crinetics Pharmaceuticals Appoints Caren Deardorf to Board of Directors
9:01am
8-K
0juyn lllmlf33
5 Jan 22
Departure of Directors or Certain Officers
5:00pm
8-K
EX-10.1
kf3 5ss9p
23 Dec 21
Departure of Directors or Certain Officers
4:30pm
424B5
m6ta 1yrseho6dcl3jg
21 Oct 21
Prospectus supplement for primary offering
4:26pm
8-K
EX-1.1
sfbmzg
21 Oct 21
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:24pm
424B5
pqn 8b9wknbgdz
20 Oct 21
Prospectus supplement for primary offering
4:15pm
8-K
EX-99.1
yb7w78yf00s6wb6ua
15 Sep 21
Regulation FD Disclosure
4:05pm